198 related articles for article (PubMed ID: 31900636)
21. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
22. Unusual synchronous double primary treatment-naïve lung adenocarcinoma harboring T790M and L858R mutations in early-stage lung cancer.
Weng CF; Chen PJ; Tseng AH; Huang SH; Lee HH
World J Surg Oncol; 2019 Aug; 17(1):148. PubMed ID: 31426797
[TBL] [Abstract][Full Text] [Related]
23. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
[TBL] [Abstract][Full Text] [Related]
24. Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis.
Terraf P; Sholl LM; Davids MS; Awad MM; Garcia EP; MacConaill LE; Dal Cin P; Kim A; Lindeman NI; Stachler M; Hwang DH; Dubuc AM
Cold Spring Harb Mol Case Stud; 2021 Aug; 7(4):. PubMed ID: 34074652
[TBL] [Abstract][Full Text] [Related]
25. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
26. Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers.
Chen K; Chen W; Cai J; Yang F; Lou F; Wang X; Zhang J; Zhao M; Zhang J; Wang J
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):371-379.e1. PubMed ID: 29092754
[TBL] [Abstract][Full Text] [Related]
27. KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.
Takanashi Y; Tajima S; Hayakawa T; Neyatani H; Funai K
Int J Clin Exp Pathol; 2015; 8(11):15338-43. PubMed ID: 26823891
[TBL] [Abstract][Full Text] [Related]
28. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
[TBL] [Abstract][Full Text] [Related]
29. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of lymph node micrometastasis at the pN₀ stage of lung adenocarcinoma using a combination of markers.
Liu H; Ye YK; Li GM; Zhou Y; Han KB; Xu G; Wang D
Genet Mol Res; 2014 Jul; 13(3):5594-600. PubMed ID: 25117316
[TBL] [Abstract][Full Text] [Related]
31. Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations.
Wang SXY; Lei L; Guo HH; Shrager J; Kunder CA; Neal JW
Lung Cancer; 2018 Aug; 122():187-191. PubMed ID: 30032829
[TBL] [Abstract][Full Text] [Related]
32. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
Takahashi Y; Shien K; Tomida S; Oda S; Matsubara T; Sato H; Suzawa K; Kurihara E; Ogoshi Y; Namba K; Yoshioka T; Torigoe H; Yamamoto H; Soh J; Toyooka S
Cancer Sci; 2018 Nov; 109(11):3634-3642. PubMed ID: 30216592
[TBL] [Abstract][Full Text] [Related]
33. Pathologic Staging and Survival of Patients With Synchronous Bilateral Lung Carcinomas.
Walts AE; Mirocha JM; Leong T; Marchevsky AM
Am J Clin Pathol; 2016 Feb; 145(2):244-50. PubMed ID: 26796494
[TBL] [Abstract][Full Text] [Related]
34. CDK1 serves as a potential prognostic biomarker and target for lung cancer.
Li M; He F; Zhang Z; Xiang Z; Hu D
J Int Med Res; 2020 Feb; 48(2):300060519897508. PubMed ID: 32020821
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.
Zhou J; Sanchez-Vega F; Caso R; Tan KS; Brandt WS; Jones GD; Yan S; Adusumilli PS; Bott M; Huang J; Isbell JM; Sihag S; Molena D; Rusch VW; Chatila WK; Rekhtman N; Yang F; Ladanyi M; Solit DB; Berger MF; Schultz N; Jones DR
Clin Cancer Res; 2019 Dec; 25(24):7475-7484. PubMed ID: 31455678
[TBL] [Abstract][Full Text] [Related]
36. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.
Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
[TBL] [Abstract][Full Text] [Related]
37. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
[TBL] [Abstract][Full Text] [Related]
39. A novel NGS-based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients.
Zhang X; Fan X; Sun C; Wang L; Miao Y; Wang L; Yang P; Xu Y; Ren X; Wu X; Xu S
J Pathol Clin Res; 2023 Mar; 9(2):108-120. PubMed ID: 36579550
[TBL] [Abstract][Full Text] [Related]
40. Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort.
Zhu D; Cao D; Shen M; Lv J
BMC Cancer; 2021 Feb; 21(1):176. PubMed ID: 33602172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
